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PATIENT RECOURSE IN INTERNATIONAL
HEALTHCARE:
ARBITRATION AND INSURANCE FOR SELFREFERRED PATIENTS
Thomas S. Terranova*
I. INTRODUCTION

M

odern patients travel extensively for healthcare, across town,
across the country, around the world, facilitated by free flowing
information and the ability to travel anywhere on the globe. They do
so for any number of reasons, and the treatment models under which
they receive care are almost infinitely numerous because international
healthcare is a vast and diverse marketplace. This Article considers
the options available to patients when treatment in the international
arena does not go as planned. Economic realities often pose a difficult
choice to patients: they can either seek care abroad with no
established recourse for medical malpractice, or they can remain in
the United States without the resources to obtain needed services;
stated simply, no care or no recourse.1 For the purposes of this Article,
first assume patients seek care from a trained medical professional in
a facility that, at minimum, purports to provide medical services.
Although hotel room surgeries, in a completely inappropriate setting,
or surgeries performed by people merely posing as doctors do occur,
*

J.D./M.B.A. Candidate, May 2017, Loyola University Chicago School of
Law. M.A. June 2007 The University of Chicago Committee on International
Relations. The author would like to gratefully acknowledge Massimo Manzi, the
Executive Director of PROMED for sharing so many documents and thoughts on
this subject.
1
See I. GLENN COHEN, PATIENTS WITH PASSPORTS: MEDICAL TOURISM, LAW,
AND ETHICS 96-97 (OXFORD UNIV. PRESS ed., 2014).
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these are not considered in this Article. Second, presume that patients,
particularly Americans, expect an avenue to collect damages in the
case of malpractice. Tort law demands holding parties responsible for
injuries they cause, and the principle permeates not only American
jurisprudence but also daily life and concepts of fairness. Therefore,
the patients whose recourse this Article considers, traverse borders to
receive legitimate medical care and expect some opportunity to
recover damages—a fundamental concept of common law. The
following pages discuss emerging options to provide patients with the
expected level of protection by offering avenues for recovery while
maintaining sufficient competitive advantages and protections to keep
doctors participating in international healthcare. In order to keep this
endeavor manageable, this Article only addresses a specific group of
international healthcare patients; however, the concepts are broadly
generalizable.
The rest of this Article discusses the current situation in
international healthcare and examines attractive early stage options
for patient recourse. Section II provides basic background information
about the phenomenon of international healthcare. Section III
discusses the size and scope of international healthcare and focuses
the conversation on the market segment being examined here. In
Section IV, the Article examines the medical malpractice gap for
international patients and its impact on patients, their native countries,
the physicians, and the treating countries. Section V explores Costa
Rica’s alternative dispute resolution scheme as offering a potential
solution for the remedy gap that is worthy of further experimentation.
Section VI examines procedure-specific insurance products as a way
to protect patients and providers from the financial ramifications of
malpractice. Finally, Section VII of this Article concludes that
international arbitration and one-time insurance regimes provide the
bases upon which a framework should be built to offer recourse to
patients.
II. THE GLOBAL HEALTHCARE MARKETPLACE: BACKGROUND AND
CONCERNS
Medical Travel, Medical Tourism, Health Travel or any of the
other seemingly infinite iterations of the term describing this concept,
is a major and growing part of healthcare that simply cannot be
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ignored, with an estimated market of approximately $50 billion in
2014.2 However, to discuss the topic as if the patients seeking care
were a monolithic group with common interests would be a mistake.
Also, to attempt to examine the entire phenomenon is too large an
endeavor for this Article. Rather, in the following pages this Article
focuses on one class of patients and their options for remedy. This
Article deals with the hard cases by design. Emulating developments
in international healthcare that protect these patients, in turn, has
powerful implications for all international patients. There are
promising remedial concepts for self-referred outpatient care that can
easily be expanded to protect patients with more substantial
relationships to the United States’ healthcare system and institutions.
The industry is at a point of experimentation. It is inconceivable that
anyone could devise an entire system of appropriate legal remedies as
a planned concept without unintended consequences. Instead, the
international healthcare marketplace must mature organically through
competent, well-informed engagements and networks of bi-lateral
agreements to find the appropriate mix of protection and added costs
that give patients from various countries their desired level of
security. Now is the time to follow promising concepts, observe the
marketplace’s reactions, and cultivate a comprehensive system of
protections that fits the needs and expectations of the market actors.
This Article uses the term international healthcare rather than
medical tourism. While international healthcare is probably the least
used term for this sector, it is the most appropriate.3 To highlight the
travel or tourism elements of international healthcare only trivializes
care and contributes to patients making decisions with less diligence
than when making a “serious” healthcare choice. Minimizing the
healthcare features of the transaction exacerbates the deleterious
effect of marketing terms like, “minor procedure”, “minimally

2

Reenita Das, Medical Tourism Gets a Facelift…and Perhaps a Pacemaker,
FORBES
(Aug.
19,
2014,
2:48
PM),
http://www.forbes.com/sites/reenitadas/2014/08/19/medical-tourism-gets-a-faceliftand-perhaps-a-pacemaker/.
3
See David Wainer, Come for the Seven-Star Hotel, Stay for a Nose Job,
BLOOMBERG
BUSINESS
(Sept.
24,
2014,
3:01
PM),
http://www.bloomberg.com/news/articles/2014-09-24/come-for-the-seven-starhotel-stay-for-a-nose-job (exemplifying the use of luxury or adventure as the
attraction to bring patients into a country for treatment with less emphasis on care).
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invasive”, and others that lead patients to believe they face no medical
risks.
International healthcare has gained recent notoriety as a
market segment primarily because the United States has become one
of the largest exporters of patients in the world.4 Travelling abroad for
healthcare dates back to antiquity. Ancients travelled to more
hospitable destinations for mineral treatments and convalescence.5 In
more recent times, the United States was the world’s primary importer
of patients due to its advanced technology.6 The wealthy citizens of
the world frequently travelled to America for the pinnacle of specialty
care in settings like the Mayo Clinic, Cleveland Clinic, or Johns
Hopkins. And while the United States continues to attract such
patients, large areas of healthcare have increasingly become
commodity services that can be adequately delivered in many parts of
the world. As a result, Americans are being targeted as consumers for
healthcare abroad. This Article refers to them as outbound patients.
It is concerning that outbound Americans are often treated as
consumers, a market segment to be attracted and captured by foreign
providers, rather than as patients. By emphasizing travel, leisure, and
even adventure to the international patient, the healthcare aspect of the
travel becomes secondary and can deemphasize the normal risks
associated with treatment or the aftercare components of healthcare
that can affect outcomes and long-term patient health.7 Patients may
not always make their decisions based solely on the best medical fit if
their judgment is clouded by destination and activity decisions,
especially when their medical treatment has been presented as an
ancillary consideration. It is critical to focus on the healthcare aspects
of international healthcare and develop reasonable patient recourse
regimes because by potentially perverting decision-making, patients
may choose lower quality care, experience higher rates of adverse
events, and actually increase the odds of needing some method of
remediation.
4

Das, supra note 2.
Hao Li & Wndy Cui, Patients Without Borders: The Historical Changes of
Medical Tourism, 83 Issue 2 Univ. of W. Ont. Med. J. 20, 20 (2014).
6
Id.
7
See Medical Tourism, CTR. FOR DISEASE CONTROL & PREVENTION,
http://www.cdc.gov/features/medicaltourism/ (last Updated February 23, 2015)
(encouraging outbound patients to verify that any “vacation” excursions or activities
are permitted post-operatively before planning them).
5
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III. EVOLUTION AND COMMODITIZATION OF HEALTHCARE: THE
UNITED STATES’ PATIENT EXPORT AND SEGMENTATION
The global healthcare marketplace is a nascent sector and is
often incompletely represented by the media, scholars, and indeed the
industry itself. Discussions about international healthcare typically
focus on big-ticket inpatient care such as cardiac bypass or joint
replacement.8 This is true of promotional material, quality and safety
studies, and examinations of the patient’s legal recourse.9 The
international healthcare conversation is familiar with hospital
accreditation by the Joint Commission International, but there is little
discussion about patients in other settings such as ophthalmology,
oncology, diagnostic, or dental clinics. When employers’ health plans
incentivize patients to seek care in a foreign country for medically
necessary procedures, there are numerous actors who are potentially
liable for damages in American courts. The employer, insurer, and
any affiliated American healthcare institutions are potential parties for
a suit through various theories of liability, although it remains to be
seen if American courts will accept such theories.10
Nonetheless, a sizeable number of America’s outbound
international patients seek foreign care and pay out-of-pocket for any

8

See Symposium, Cross-Border Health Care: The Movement of Patients,
Providers, and Diseases. LOY. U. CHI. INT’L. L. REV. & BEAZLEY INST. FOR
HEALTH L. & POL’Y (2015) (presenting many aspects of international healthcare
focused on transplants, health justice, epidemiology, and inpatient care with no
mention of patients seeking self-funded outpatient care).
9
See Deloitte Center for Health Solutions, Medical Tourism: Consumers in
Search of Value, (2008) [hereinafter Deloitte, Consumers in Search of Value] (using
the word hospital over eighty times while referring to outpatient-only locations three
times); See also COHEN, supra note 1 at 80-86 (examining medical malpractice
liability for a hypothetical American patient primarily in the context of receiving
care at a hospital); See also Edward Kelley, Medical Tourism, Presentation to World
Health Org. Patient Safety Programme (Oct. 2, 2013) available at
http://www.who.int/global_health_histories/seminars/kelley_presentation_medical_t
ourism.pdf (discussing inpatient hospital pilot insurance programs).
10
Nathan Cortez, Recalibrating the Legal Risks of Cross-Border Health Care,
10 Yale J. Health Pol’y L. & Ethics 1, 8, 14-17 (2010) (acknowledging there are no
cases or test cases to indicate the potential liability of foreign providers or
intermediary, employers, or insurers in the United States and detailing the myriad
challenges facing a patient attempting to hold one of these parties liable in the
United States).
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number of reasons.11 Such patients may be seeking elective
procedures that are not covered by existing insurance.12 Outbound
Americans may also want procedures that are unavailable in the
United States due to legal prohibitions or a lack of regulatory
approvals, or may be looking for less expensive alternatives because
they are among the massive population of uninsured Americans, many
of whom will remain uninsured despite the Affordable Care Act.13
Patients may also go abroad for care because they are immigrants
from the treating country, want to receive care in their native land,
and possibly be cared for post-operatively by family or friends. Some
international patients are also members of the American expatriate
community who need or want care while living abroad.14
In addition to selecting care providers without being counseled
to do so by an employer, insurer, or facilitator, many patients undergo
care in outpatient settings that are less likely to have affiliations with
American institutions.15 These patients have fewer potential parties
against whom to file suit in American courts, even if case law
develops to support such liability theories in cross border healthcare.16
11

Kelley, supra note 9. (citing OECD report indicating cosmetic surgery,
elective surgery, & fertility treatment are the most common treatments in
international healthcare)
12
See Brandon Green, Dental Tourism Could Save You Big Money,
FOXNEWS.COM (Nov. 1, 2013) http://www.foxnews.com/travel/2013/11/01/savingbig-with-dental-tourism/ (noting an industry publication that estimated there would
be approximately 500,000 outbound American patients for dental treatment alone in
2013).
13
See Wendell Potter, Millions of Middle Class Americans Will Remain
Uninsured Despite Obamacare, THE CTR. FOR PUB. INTEGRITY (Feb. 2, 2015, 5:00
AM)
http://www.publicintegrity.org/2015/02/02/16681/millions-middle-classamericans-will-remain-uninsured-despite-obamacare (noting the Congressional
Budget Office estimates 31 million Americans will remain uninured in ten years);
See also COHEN, supra note 1, at 95.
14
Most estimates and statistics for international healthcare do not include
expatriates, however, these patient populations are at least relevant to consider in the
context of legal recourse. See Medical Tourism Statistics & Facts, PATIENTS
BEYOND
BORDERS,
http://www.patientsbeyondborders.com/medical-tourismstatistics-facts (last updated July 6, 2014).
15
Tilman Ehrbeck, Ceani Guevara & Paul D. Mango, Mapping the Market for
Medical Travel, McKinsey Q., May 2008, at 2-3 (recognizing that substantial
numbers of patients travel for outpatient procedures, the study also excludes
expatriates receiving care, wellness care, and emergency care).
16
See COHEN, supra note 1 at 84-85 (noting personal jurisdiction in the United
States would be easier to establish if the foreign provider actively targeted American
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So the majority of the discussion of globalized healthcare ignores
remedies for this large and very exposed subset of international
patients. If the marketplace can devise protection for these patients, it
will certainly add an extra layer of protection for those patients who
are more connected to American jurisdictions by virtue of agents who
guide care toward foreign providers. Therefore, this Article focuses
solely on American outbound healthcare, in which the patient pays
out-of-pocket and uses no professional services in choosing a
provider. This is the segment of the international healthcare market
that is hardest to protect and may include hundreds of thousands of
patients.17
IV. THE INTERNATIONAL HEALTHCARE MARKET’S REMEDY GAP
This section continues under the assumption that American
common law and jurisprudence reinforce the American patient’s
expectation to have recourse in cases of medical malpractice. Further,
it assumes the legal and regulatory communities agree that medical
malpractice remedies serve the concept of fairness by issuing
judgments against physicians who cause patient injuries. The question
remains, how can a patient receive adequate protection against
malpractice when the physician is the citizen and domiciliary of a
foreign country and has no agents within the United States?
Truthfully, little can be done to fully protect patients who
travel for healthcare because the industry represents a vast free-market
model in which patients decide how diligently and with what
protections they will participate. If adding protective remedies reduces
cost savings too much, patients may choose to go farther afield into a
less regulated market for the cheapest care. Essentially, the patients
assume the level of risk with which they are comfortable. However,
an ancillary result of medical complications is the burden on the
patient’s native health system, in this case the American healthcare
system, to perform revisions and follow-up care. Therefore,
patients or employed an intermediary to avail themselves of a state’s laws in order
to secure patients for the provider).
17
The author bases this statement on Patients Beyond Borders’ 2012 estimate
of 400,000 outbound American dental patients. If only twenty-five percent travelled
abroad without the help of an agent, the segment would include over 100,000
patients without even considering those seeking care from other medical specialties.
See Green, supra note 12.
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government agencies have a sizeable incentive to ensure adequate
patient recourse in the international healthcare arena. Finally, the lack
of clarity regarding remedies also distorts physician participation in
international healthcare.
A. Impact on the Patient Population
The uncertainty surrounding remedies has very obvious
implications for patients and their decision-making. American patients
receiving care abroad are severely limited in their ability to recover
for medical malpractice in comparison to patients treated domestically
because of issues with personal jurisdiction, forum non conveniens,
choice of laws, enforcing judgments, and suing abroad (in the treating
country).18 Since the individual patient cannot recover for
malpractice, the entire patient population is somewhat exposed
because there is no medical malpractice deterrent to dissuade
physicians from future negligent care.19 However, given the extremely
high cost of healthcare in the United States, the choice for many
patients who will pay out-of-pocket is to either accept limited or no
medical malpractice recovery, or to forego treatment altogether.20
Absent a remedy, any complications from international healthcare
require the patient to pay out-of-pocket for major follow up care. Selfpay is not an ideal situation for patients that have already made
healthcare choices based on cost. It is also possible for the patient to
secure private arrangements with the original treating physician to
correct medical errors, which is also far from ideal since the patient
may not be enthusiastic about being treated by the same physician a
second time.
The out-of-pocket patient population is a diverse group with
tremendous variation in income and sophistication.21 Therefore,
patients may calculate their selection of providers differently based on
balancing the total cost savings, the location’s or provider’s overall
quality and safety, and over time, the opportunity to recover for any
medical malpractice. Some patients will certainly sacrifice a degree of
18

These challenges are beyond the scope of this Article and are expertly
discussed in other works. see COHEN, supra note 1 at 83-89.
19
But see id. at 81-82 (acknowledging the deterrent effect of malpractice
judgments is debatable).
20
See id. at 96-97.
21
See id.
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safety and quality standardization, or the prospect of malpractice
recovery, in exchange for needed financial relief at the outset. It is
imperative to develop the means to offer patients recourse while
maintaining a sufficient enough financial incentive to keep them from
either foregoing care entirely or opting for treatment in a completely
unregulated and undeveloped medical market with a high probability
for complications. Ultimately, a system with patient remedies that
maintains significant cost savings should result in the channeling
regime favored by Professor I. Glenn Cohen.22 Whether channeling is
an organic product of the industry or a formal recognition process
devised through an agency such as the State Department or
Department of Health and Human Services is unimportant, so long as
the patient understands the treatment and remedy options available
and no longer faces the choice of no care or no recourse.
B. Exposing the Home Country
The patient’s choice to seek care abroad has important
implications for the health system of the patient’s home country.
Should complications arise after international healthcare, particularly
acute adverse events requiring immediate medical attention, the
American public health system will likely have to assume the
responsibility of treating the patient. As discussed above, the selffunded market segment at issue in this Article is likely uninsured or
underinsured,23 leaving a sizeable portion of the financial burden on
public institutions.
Although this Article specifically addresses outbound
American patients, the British National Health System (NHS)
provides useful analogous data that might suggest the total cost
incurred by American taxpayers to treat complications for
international healthcare.24 In 2010 the NHS estimated 1,890
22

See id. at 108-15 (acknowledging that a ban on international healthcare is
unlikely and would be ineffective, and discussing disclosing medical malpractice
remedies or requiring remedies as conditions for official American agency approval
to incentivize countries to adopt medical malpractice regimes and influence patient
decision making).
23
See id. at 96-97.
24
See Neil Lunt, et al., Implications for the NHS of inward and outward
medical tourism: a policy and economic analysis using literature review and mixedmethods approaches, 2 Issue 2 HEALTH SERV. & DELIVERY RES. at 83, 87, 111-112
(2014).
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international patients would need follow up care at a cost of
approximately £8.2 million.25 This figure is based only on the
estimated 18,900 outbound British patients who sought cosmetic care
abroad.26 Meanwhile, the entire British outbound international patient
population in 2010 was only about 63,000.27 Compare the British
figure with the approximately 875,000 Americans who travelled
abroad for care that same year.28 Assuming public programs also treat
the majority of American complications and that complications occur
at a comparable rate as they do for British patients, the estimated cost
of complications on the United States’ health system is staggering.
To date, there is insufficient data to calculate whether the costs
of treating those complications outweigh the overall savings that
outbound tourism bestows on the health system. However, whether
international healthcare is a net profit or loss for the American health
system is irrelevant. Tort law demands judgments in favor of a
plaintiff be imposed on the party responsible for causing an injury, not
incurred by an innocent third party. Therefore, should international
healthcare procedures result in complications from malpractice, there
must be a system of redress that absolves the patient’s home country
from shouldering the cost of the foreign physician’s tortious act. To
impose the cost of errors on the federal or state governments
(effectively the taxpayers), violates the concept of fairness and
stretches the rational limits of proximate causation. Instead, the
physician must be held responsible for any negligence or malpractice
directly, but in a manner that does not scare them out of international
healthcare entirely.

25

Id. at 111.
See id. (calculating the number of patients travelling for cosmetic treatment
based on IPS data and several surveys).
27
Johanna Hanefeld, et al., Abstract, Medical Tourism: a Cost or Benefit to the
NHS,
PLOSONE
(Oct.
24,
2013)
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0070406#reference
s.
28
Duncan McGowan, The Rise of Medical Tourism in Panama, VACATION
NEWS (Oct. 17, 2013, 11:04 AM) http://www.worldpropertyjournal.com/featuredcolumnists/the-panama-wire/medical-tourism-panama-healthcare-costs-medicalprocedures-medical-tourists-cosmetic-surgery-fertility-treatments-dental-implantshospital-punta-pacifica-7514.php.
26
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C. The Physician’s Catch 22
In the absence of a malpractice regime, American patients face
the choice of no care or no remedy. Treating physicians, on the other
hand, must decide whether to cede jurisdiction to the American court
system, offer no additional protection and potentially scare off
patients, or devise a private offering to ease any lingering patient
fears. Of all the areas of international healthcare presenting a dearth of
information, the physicians’ decision making is the least documented.
Physicians who work in international healthcare are a sophisticated
group of actors, many of whom are familiar enough with American
medical malpractice judgments to know that they do not want to be
subject to American judgments. If physicians did choose to submit to
American jurisdiction, adequately protecting themselves from
devastating judgments would raise expenses through additional legal,
insurance, and administrative fees. It would diminish the cost savings
they offer to Americans and damage their value propositions. For the
same reasons a patient may want to subject a doctor to American
jurisdiction, no logical doctor would contract to become subject to
American courts.
However, physicians do understand that American patients
expect some protection. Failing to provide any remedial option
diminishes the physician’s offering and potentially keeps patients out.
As a compromise, many physicians offer to conduct follow-ups or
corrections at no cost, or pay for the cost of additional services
necessitated by a bad outcome. Once a patient has a complication,
however, it is safe to assume that the relationship has become
somewhat damaged and the patient may not be willing to trust the
operating physician to treat them again, or even to pay for adequate
treatment. The system needs something more structured. Physicians
and their home countries have an incentive to provide reasonable
recourse without submitting to American jurisdiction and being
exposed to the risk of the rare mega judgments it produces. They must
provide some protection, or risk losing any competitive edge they
might have over American healthcare. In the case of the treating
country, spoiling inbound international healthcare jeopardizes
potentially billions of dollars in revenue.
D. National Embarrassment to the Treating Country
International healthcare is a matter of national importance for
several countries at the forefront of the industry. Some governments
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have identified international healthcare as a major national strategic
imperative and now compete with the rest of the globe to advance
their own particular market offering.29 The billions of dollars at stake
annually justify a major national investment. A prime example is
South Korea, which founded the Korea Health Industry Development
Institute (KHIDI), a public-private institution, in 1998.30 The institute
has a twofold purpose to improve the national health industry and
strengthen the international competitiveness of the Korean health
industry.31 KHIDI has an annual budget of $400 million, employs
approximately 400 people, and maintains six offices outside of
Korea.32 Similarly, Costa Rica identified quality healthcare and
English language penetration among its own competitive advantages
and created the Council for the International Promotion of Costa Rica
Medicine (PROMED) to advance the country’s interests in the
international marketplace.33 In 2015, PROMED will host its fifth
annual summit series on international healthcare, the second year in
which events are set to take place inside the United States.34
The above are just two examples of the increasingly common
strategic national investments countries have made to attract
international patients. There are similar organizations throughout the
world but it is unnecessary to detail them all, rather, it is sufficient to
note that multiple nations devote millions of dollars toward

29

See Deloitte, Consumers in Search of Value, supra note 9, at 6 (identifying
10 hubs for international healthcare Brazil, Costa Rica, Gulf States, Hungary, India,
Malaysia, Mexico, Singapore, South Africa & Thailand & substantial efforts in the
Philippines & South Korea).
30
History,
KOREA
HEALTH
INDUS.
DEV.
INST.,
http://www.khidi.or.kr/board?menuId=MENU00773 (last visited Feb. 23, 2015).
31
Purpose of the Institute, KOREA HEALTH INDUS. DEV. INST.,
http://www.khidi.or.kr/board?menuId=MENU00772 (last visited Feb. 23, 2015).
32
About,
KOREA
HEALTH
INDUS.
DEV.
INST.,
http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&
uact=8&sqi=2&ved=0CDcQFjAD&url=http%3A%2F%2Fwww.khidi.or.kr%2Ffile
Download%3FtitleId%3D106281%26fileId%3D2&ei=2rTrVKgrieewBNbpgoAG&
usg=AFQjCNG9ayUzU1AQA5N5Ne5nHt-N0p8riA&bvm=bv.86475890,d.cWc
(downloaded Feb. 23, 2015).
33
About PROMED, COUNCIL FOR THE INT’L PROMOTION OF COSTA RICA MED.,
http://www.promedcostarica.org/about/ (last visited Feb. 23, 2015) [hereinafter
About PROMED].
34
Home,
MED.
TRAVEL
INT’L.
BUS.
SUMMIT,
http://themedicaltravelsummit.com/ (last visited Mar. 31, 2015).
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developing and promoting their international healthcare programs.35
Treating countries have the same incentives as individual treating
physicians to offer satisfactory avenues to malpractice recovery. The
main difference is that the national strategic interest magnifies the
individual concerns of the physician because it aggregates the
earnings from all inbound patients. National economic interests also
include those from ancillary services related to care and recovery as
well as hotels, meals, and non-health related services and
excursions.36 The stakes are high; patients may be scared off in droves
to pursue care in a competing nation because of high-profile
complications in which the patient was unable to recover. Treating
countries may lose out on tens of millions of dollars of income.
Recently a British patient died after undergoing surgery in Thailand,
the media coverage highlighted the potential financial ramifications of
bad outcomes on treating countries.37
It is in the best interest of treating countries to help formalize
an international regime for patient recovery because leaving patients
financially exposed to adverse outcomes threatens the long-term
viability of a national economic sector potentially worth millions.
Each adverse outcome in which the patient does not receive
satisfactory compensation increases the chances of negative public
35

There is no consolidated list of official or semi-official national promotion
organizations. See e.g. Medical Clusters in Mexico, MEX. TOURISM BD.,
https://www.visitmexico.com/en/health/hospitals/medical-clusters-in-mexico (last
visited Mar. 30, 2015); see also e.g. Thailand Medical Tourism Portal, TOURISM
AUTH. OF THAI., http://www.thailandmedtourism.com/Home/28 (last visited Mar.
30, 2015); see also e.g. Medical Travel, SING. TOURISM BD.,
https://www.stb.gov.sg/industries/healthcare (last visited Mar. 30, 2015); see also
e.g. 2014 Sponsors: World Medical Tourism & Global Healthcare Congress, MED.
TOURISM ASS’N., http://www.medicaltourismcongress.com/2014-sponsors/ (last
visited Mar. 30, 2015).
36
JOHN CONNELL, MEDICAL TOURISM 132-133 (Sarah Hulbert & Shankari
Wilford eds., 2011) (noting medical tourists spend two to three times more than
standard tourists with a significant amount of spending outside of healthcare and
creating many non-healthcare jobs).
37
Francesca Infante, British Woman Who Died in Thailand During Buttock
Surgery as Brother Reveals Family 'Still Don't Know What Went Wrong', THE
DAILY MAIL (Oct 29, 2014, 7:24 PM), http://www.dailymail.co.uk/news/article2813420/Pictured-British-woman-died-Thailand-buttock-surgery-brother-revealsfamily-don-t-know-went-wrong.html (explaining the patient died as a result of
corrective surgery when her implants became infected, also noting Thailand made
£2.68 billion from inbound international healthcare in 2013).
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perception and heightened discourse over the ability of treating
physicians and advisability of receiving care in the treating country.
Creating a robust scheme for patient recourse makes it clear that the
treating physician and treating country are responsible, have given
adverse outcomes sufficient forethought, and have instituted a
reasonable method of resolving disputes.
V. EXPERIMENTING WITH ARBITRATION SCHEMES OFFERS THE
PROSPECT OF ADEQUATE REMEDY
Ultimately, whatever available safeguards can be implemented
to protect patients and the national healthcare system should surely be
implemented. In fact, reasonable malpractice remedies are in the best
interest of all stakeholders and are beginning to crystallize in
international healthcare. International healthcare transactions are, by
nature, bi-lateral arrangements. The patient’s home country, the
United States for this Article, represents one side of the transaction
and the treating country represents the other. The United States
generally has some sort of broader trade relationship with the treating
country, as long as the patient does not undergo treatment in an
embargoed nation such as Iran or North Korea. It therefore makes
sense to look to those existing relationships for ideas to model a
liability and dispute resolution system that will function globally.
Bi-lateral alternative dispute resolution schemes are those in
which the patient’s home country and the treating country recognize
the validity of arbitration and conciliation awards in each other’s
territory and have established at least one organization that is
sufficiently impartial to conduct an unbiased process.38 Such
programs provide legitimate patient recourse that bridges the gap
between an acceptable legal remedy and a wild-west medical
environment offering no legal recourse, thus avoiding all
administrative and transaction costs associated with a malpractice
38

The Costa Rican-American Chamber of Commerce houses the Arbitration
and Conciliation International Center and enjoys nearly equal membership from the
United States and Costa Rica. The Chamber accounts for the majority of Costa
Rica’s foreign direct investment and exports. This organization has an incentive to
provide an unbiased process for claims between Americans and Costa Rican’s
because it represents the interests of both parties. See About Us, THE COSTA RICANAM. CHAMBER OF COM., http://www.amcham.co.cr/about_amcham.php (last visited
Feb. 12, 2015) [hereinafter About Us, Am-Cham].
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process. As discussed above, physicians treating American patients
are well aware of the ramifications of medical malpractice suits and
the reputation of the United States court system for granting large
judgments. These sophisticated actors often make a conscious
decision to limit their exposure while offering patients some measure
of protection. One thing patients and lawyers can be sure of is that
these doctors will not willingly cede jurisdiction to the United States.
However, most physicians are aware that failing to provide any
recourse will eventually scare off a large number of patients.
Costa Rica is a leading provider of healthcare to outbound
American patients and offers a regime that may provide a path
forward. Costa Rica has based its development on its human
intellectual capital, with a well-educated but fairly inexpensive
workforce.39 The country considers medical travel a strategic national
imperative and has committed to quality throughout the healthcare
system.40 The country established the Council for the International
Promotion of Costa Rica Medicine (PROMED) as a non-profit
organization to position Costa Rica as a leader in international
healthcare.41 PROMED first attempts to limit adverse outcomes by
requiring all members providing healthcare or ancillary services to
meet all national licensing standards as well as to achieve
international accreditation generally recognized in the United States,
Canada, or Europe.42
It is admirable that Costa Rica attempts to avoid catastrophes
by only allowing the highest quality providers to participate in its
national promotion scheme. For the purposes of medical malpractice
remedies, however, the country’s solution to post-treatment patient
dispute resolution is more valuable for study and imitation. In addition
to offering international quality, Costa Rica offers internationally

39

Andrès Rodrìguez-Clare, Costa Rica’s Development Strategy Based on
Human Capital and Technology: How It Got There, the Impact of Intel, and Lessons
For Other Countries. UN DEV. PROGRAMME 1, 16-17 (2001). available at
http://eml.berkeley.edu/~arodeml/Papers/CRDevelopmentStrategy.pdf.
40
Decretos N°35054-S-COMEX-COM-TUR. 34 LA GECETA 2 (Feb. 18, 2009)
available at http://www.gaceta.go.cr/pub/2009/02/18/COMP_18_02_2009.html.
41
About PROMED, supra note 33.
42
PROMED: Requirements For Membership, COUNCIL FOR THE INT’L
PROMOTION OF COSTA RICA MED., http://www.promedcostarica.org/joinpromed/membership/requirements (last visited Feb. 23, 2015).
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acceptable options for legal recourse.43 To that end, PROMED advises
its members to use alternative dispute resolution by including an
arbitration clause in their contracts with patients.44 PROMED
endorses the Arbitration and Conciliation International Center (CICA)
housed at the Costa Rican–American Chamber of Commerce
(AmCham) to settle disputes.45
AmCham is more than forty years old.46 The organization’s
membership is approximately 400 companies and 1,300 corporate
representatives with about equal distribution between Costa Rican and
American members.47 Additionally, AmCham is responsible for about
eighty percent of Costa Rica’s foreign direct investment and
approximately the same percentage of Costa Rican exports.48 CICA
was founded in 1999 and is a non-profit entity dedicated to providing
conciliation and arbitration services to resolve commercial disputes.49
CICA promotes the fact that its conciliation and arbitration processes
resolve ninety-five percent of controversies presented.50 Further,
CICA’s arbitration process has a maximum time limit of seven
months.51 Alternative dispute resolution is an attractive option
compared to the unpredictable and lengthy processes offered by the
Costa Rican court system.52 Even if it takes twice as long to settle a

43

CICA: International Center for Conciliation & Arbitration, COUNCIL FOR
PROMOTION OF COSTA RICA MED., http://www.promedcostarica.org/joinpromed/membership/benefits/conflict-resolution/ (last visited Feb. 11, 2015)
[hereinafter PROMED, CICA].
44
Costa Rica Safe Destination for Medical Travelers, COUNCIL FOR THE INT’L
PROMOTION OF COSTA RICA MED., (unpublished promotional material) (on file with
PROMED) [hereinafter Costa Rica Safe Destination].
45
Id.
46
About Us, Am-Cham, supra note 38.
47
Id.
48
Id.
49
About Us, ARBITRATION AND CONCILIATION INT’L. CTR.,
http://www.cica.co.cr/pages/cica (last visited Feb. 12, 2015) [hereinafter CICA,
About Us].
50
Id.
51
Id.
52
PROMED, CICA, supra note 43 (“PROMED supports the alternative dispute
resolution (ADR) process because resolution of a dispute, depending on the
complexity of the case, could take years in the Costa Rican courts and with no
guarantee of a satisfactory result for either party”).
THE INT’L
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case as CICA’s maximum limit allows, malpractice claims would be
resolved long before the average case in American courts.53
PROMED, Costa Rica’s government ministries, and the
medical community recognize that the country’s medical
infrastructure, educational capacity, human intellectual capital, natural
beauty, and English proficiency make an attractive offering.54
However, they also realize that the offering is incomplete if the
country and its healthcare providers fail to make patients feel secure
by offering a remedy for malpractice.55 All industry actors are
concerned with the prospect of being held liable for malpractice
against an American patient because of America’s reputation for
litigation and large financial awards.56 So, no competent foreign
physician will willingly submit to American jurisdiction. PROMED,
therefore advises healthcare providers to offer conflict resolution as
one of four necessary components of making Costa Rica a safe
healthcare destination and establish the country as a leader in
international healthcare.57 Conflict resolution through CICA is so
central to Costa Rica’s value proposition that the organization
provides members with boilerplate conciliation and arbitration clause
language.58
Despite the common criticisms of arbitration in general, the
regime offered by CICA is equivalent to arbitration regimes to which
American patients may freely contract when receiving domestic care.
In fact, CICA boasts a cooperative agreement with the International
Section of the American Arbitration Association (AAA).59 CICA’s
published rates60 are comparable to those published by AAA for either
53

Jena Anumpam, et al., Outcomes of Medical Malpractice Litigation Against
US Physicians, 172 No. 11 JAMA Internal Medicine (2012), available at
http://archinte.jamanetwork.com/article.aspx?articleid=1151587 (finding the mean
length of a litigated malpractice case in the United States to be 25.1 months).
54
Stephen Wiener Esq., An Introduction to Legal Issues In Medical Travel:
What to Worry About, or Not, Presentation at The Medical Travel International
Business Summit. San Jose, Costa Rica (May 2-4, 2011).
55
Id.
56
Id.
57
Costa Rica Safe Destination, supra note 44.
58
Id.
59
CICA, About Us, supra note 49.
60
Tarifas,
ARBITRATION
AND
CONCILIATION
INT’L.
CTR.,
http://www.cica.co.cr/pages/tarifas (last visited Feb. 12, 2015) [hereinafter CICA,
Tarifas].
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general arbitration61or the International Centre for Dispute
Resolution.62 Similarly, all of these organizations offer arbitration by
single neutral parties or tribunals.63
Based on the equal distribution of interests and financial
commitments between the United States and Costa Rica in
AmCham’s membership, American patients are not likely to suffer at
the hands of a bias and hostile system. CICA has significant
incentives to provide fair and equitable resolutions. In addition, the
American judicial system is not overly friendly to malpractice
plaintiffs. The court dismisses more than half of all claims, and
approximately eighty percent of the small number of cases resulting in
verdicts find in favor of the physician.64 American patients are free
when undergoing care in the United States to either contract for
alternative dispute resolution or, absent an agreement, to bring a claim
in America’s less than hospitable court system. It is no great gamble
to rely on arbitration in CICA. The only difference is that a clause
requiring conciliation and arbitration under CICA would likely
remove the slight but important chance for the mega awards that have
given America its reputation in the international community. Some
American courts have even recognized the practical benefits of
arbitration over the judiciary.65
As two of the nations that have ratified the New York
Convention,66 the United States and Costa Rica agree to the

61

Costs of Arbitration (including AAA Administrative Fees), AM. ARBITRATION
ASS’N., https://www.adr.org/aaa/ShowPDF?doc=ADRSTAGE2026862 (last visited
Feb. 12, 2015) [hereinafter Costs of Arbitration].
62
International Dispute Resolution Procedures (Including Mediation and
Arbitration
Rules),
A M.
ARBITRATION
ASS’N.,
https://www.adr.org/aaa/ShowPDF?doc=ADRSTG_004338 (last visited Feb. 13,
2015) [hereinafter International Dispute Resolution].
63
CICA, Tarifas, supra note 60; Costs of Arbitration, supra note 61;
International Dispute Resolution, supra note 62.
64
Amy Norton, Docs Win Most Malpractice Suits, but Road is Long, REUTERS
(May 23, 2012), available at http://www.reuters.com/article/2012/05/23/us-docswin-most-idUSBRE84M11N20120523.
65
See COHEN, supra note 1, at 104 (discussing Madden v. Kaiser Found.
Hosps., 552 P2d 1178, 1185-86 (Cal. 1976), that arbitration offers a venue for minor
malpractice claims that cannot economically be resolved in the courts).
66
New York Convention Countries, N.Y. ARBITRATION CONVENTION,
http://www.newyorkconvention.org/contracting-states/list-of-contracting-states (last
visited Feb. 20, 2015).
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fundamental characteristics of arbitration and recognize the validity of
the arbitration process employed in each other’s jurisdiction.67 This
provides a solid, legitimate foundation capable of supporting an
adequate alternative dispute resolution regime. Widespread accession
to the New York Convention by so many countries68 indicates that
despite general questions about the validity of arbitration, there is
broad international agreement about the process. Thus, this allows
many nations to provide a sufficient alternative dispute resolution
regime to adequately protect American patients.
The industry must build upon the foundation of bi-lateral
arbitration recognition with alternative dispute resolution institutions
that are somewhat equally supported by the United States and the
treating country. One of CICA’s most attractive features is that it
represents both American and Costa Rican business interests.69
Despite the fact that CICA has yet to adjudicate an international
medical malpractice claim, the organization’s equity of interests
imbues it with credibility and suggests a degree of impartiality that is
critical to international healthcare. The international healthcare market
must experiment with these regimes and encourage copycat
institutions to evolve organically by learning from awards and patient
behavior to strike the right cord. Ratification of the New York
Convention and an alternative dispute resolution scheme housed in a
bi-laterally funded organization are essential to the early iterations
because such regimes will give patients enough of a sense of home to
feel adequately protected.
The Costa Rican model offers quality, safety, and alternative
dispute resolution. It presents a mix of risk mitigating safeguards and
remedial protections that reduce the likelihood of complications and
increase the chances of satisfactory dispute outcomes. The system is
worthy of imitation and expansion. Based on America’s pervasive
trade relationships with almost every country where a patient may
seek care, similar safety and recourse layering may already exist in
67

Convention on the Recognition and Enforcement of Foreign Arbitral Awards
art. III, United Nations Conference on International Commercial Arbitration (1958).
68
See Bhutan and Guyana Accede to the Convention on the Recognition and
Enforcement of Foreign Arbitral Awards, UN INFO. SERV. (Sept. 26 2014),
http://www.unis.unvienna.org/unis/en/pressrels/2014/unisl207.html (indicating The
Convention it went into force on December 24, 2014 in both countries bringing the
number of state parties to 152).
69
CICA, About Us, supra note 49.
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other international healthcare providing nations, or if not, the
infrastructure may be readily available to create them. The American
Chamber of Commerce has chapters similar to Costa Rica’s AmCham
in more than ninety foreign countries.70 Each Chamber could support
an organization like CICA, if it does not already, particularly where
the host nation has contracted to the New York Convention. This type
of arbitration relationship requires not only the national relationships
to foster a fair alternative dispute resolution forum, but the
commitment and sophistication of the physician population to offer
such a contract provision and well-informed patients to demand such
clauses.
Interested parties such as outbound patients, patients’ rights
groups, treating physicians, attorneys, and United States government
agencies are the stakeholders most appropriate to drive the
development of alternative dispute resolution regimes in other
countries. The stakeholders should encourage the various Chambers
of Commerce to create arbitration bodies that equally represent the
interests of both the American patient and the treating physician. The
nations involved must recognize each other’s processes to legitimatize
the scheme and then build an institution with equal representation
from each country, based on existing trade relationships if necessary.
Self-referred outbound American patients will then be covered by a
network of bi-lateral arrangements that provide remedial protections
consistent with the patient’s expectation for fair compensation in
cases of medical malpractice. Most important, alternative dispute
resolution must develop a fair and equitable process patients can trust
without scaring off physicians based outside the United States. Once a
global network of alternative dispute resolution venues develops, it
will become incumbent upon attorneys to ensure their clients do not
merely jump at the least expensive offer or the flashiest website and
leave themselves exposed.
VI. ELECTIVE PROCEDURE INSURANCE PROVIDES ADDITIONAL MEANS
OF RECOVERY FOR THE INTERNATIONAL PATIENT
One-time procedure insurance offers an additional layer of
protection by vetting participating physicians and providing a
70

American Chambers of Commerce Abroad (AmCham) Results for Region,
CONN. BUS. & INDUS. ASS’N., http://www5.cbia.com/business/american-chambersof-commerce-abroad-amcham-results-for-region/ (last visited Feb. 25, 2015).
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financial safety net accessible by patients with complications resulting
from international healthcare. Procedure-specific insurance programs,
especially when paired with alternative dispute resolution schemes
such as the one discussed above, provide sufficient protections for
patients as well as the health system of the patient’s home country.
The International Society of Aesthetic Plastic Surgeons
(ISAPS) has partnered with an insurer to provide international
coverage for complication and revision treatments for outbound
British patients. The program is called ISAPS Insurance and is
provided by Sure Insurance Services Limited.71 The insurance plans
attempt to keep the rate of complications consistent with high-quality
care provided around the globe. This and similar regimes protect
patient interests and allay physicians’ concerns over major financial
damages enough to keep them involved in the international healthcare
marketplace.
This procedure-specific insurance offers an additional layer of
protection by vetting participating physicians as well as providing a
financial safety net. The ISAPS Insurance program is available
exclusively to ISAPS member surgeons.72 ISAPS membership, and by
extension the insurance policy, requires participating surgeons to be
board certified or the local equivalent in countries without official
board certification.73 By requiring board certification or its equivalent,
the society and insurance program seek to assure the highest levels of
clinical competency and specialty training.74 The mitigating effect of
such a requirement theoretically drives down the need for patient
claims.
In the event of a complication, however, The ISAPS Insurance
program offers protection to the patient, the patient’s home country,
and the physician through various instruments. Such programs,
71

Who We Are, ISAPS INS., http://isapsinsurance.com/ (last visited Jan. 20,

2015).
72

The Policy, ISAPS INS., http://isapsinsurance.com/the-policy (last visited Jan.
20, 2015).
73
International Society of Aesthetic Plastic Surgery By-Laws, INT’L SOC’Y OF
AESTHETIC
PLASTIC
SURGERY,
http://www.isaps.org/Media/Default/downloads/ISAPS-By-Laws.pdf (last visited
Jan. 20, 2015).
74
See Susumu Takayanagi, MD., A Letter from the President of ISAPS, INT’L
SOC’Y OF AESTHETIC PLASTIC SURGERY, http://www.isaps.org/about-isaps/letterfrom-president (last visited Jan. 20, 2015).
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especially when paired with an alternative dispute resolution scheme,
provide sufficient protections for all parties.
A. Covering the Patient
The ISAPS Insurance program covers patients and
companions through three different instruments sold under the
product name Medical Travel Shield (MTS).75 The plans are divided
into three products that cover international dental treatment, cosmetic
surgery, and elective surgery or in vitro fertilization treatment. 76 All
three products cover various travel related incidents as well as certain
medical circumstances for patients between eighteen and sixty-six
years old.77 The plans provide for corrective treatments, but do not
cover medical or legal costs related to the planned treatment.78 This is
why it is so important to pair this type of instrument with an
appropriate method of recovery (e.g., arbitration), in order to fully
protect the patient. Any disputes arising out of the policy are governed
by the patient’s home country, in this case, England and Wales, and
bring these claims firmly back into familiar jurisdiction.79
The policy ensures the patient receives necessary care up to £2
million in the event of a serious incident, including a life threatening
complication during the planned procedure and the cost of
repatriation.80 Covered patients also receive a £50 daily hospital

75

The Product, MED. TRAVEL SHIELD, http://medicaltravelshield.com/ (last
visited Feb. 22, 2015).
76
Id.
77
Medical Travel Shield Key Facts Document: For Persons Travelling Abroad
to
Receive
Dental
Treatment,
MED.
TRAVEL
SHIELD,
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015);
Medical Travel Shield Key Facts Document: For Persons Travelling Abroad to
Receive
Elective
Surgery,
MED.
TRAVEL
SHIELD,
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015);
Medical Travel Shield Key Facts Document: For Persons Travelling Abroad to
Receive
Cosmetic
Surgery,
MED.
TRAVEL
SHIELD,
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015)
[hereinafter cited collectively as MTS Key Facts] The forms are substantially similar
in content and format, except each corresponds to coverage for a different type of
care. The collective citation indicates the breadth of services covered. Subsequent
pin cites reference the location of content on each of the three forms.
78
See, MTS Key Facts, supra note 77, at 2.
79
See MTS Key Facts, supra note 77, at 3.
80
See MTS Key Facts, supra note 77, at 4, 5.
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benefit up to a maximum of £1,500, up to £500 for additional foreign
healthcare consultations before returning home, and up to £2,000 to
return to the original treating hospital within twelve months for any
required corrective treatment.81 It is quite difficult to obtain exact
prices because of the pricing structure for insurance. However, the
insurance program offers exemplars that suggest patients can protect
themselves for a modest investment, especially considering the cost
savings usually associated with foreign treatment.82 One such example
is a policy covering a seven-day trip from the United Kingdom to
Poland for elective surgery that costs £191.50.83
Patients must keep in mind they are receiving medical care,
not a “minor procedure” that is treated with little more concern than a
haircut. Purchasing coverage will slightly reduce their substantial
savings but will cost less than many insured patients pay for one
month’s premium, therefore it should not be too unpalatable.84 The
ISAPS Insurance discussed here is currently limited to patients from
Britain, but it should be replicated and tried in the United States. The
model employed by the policies,85 which only covers supremely
trained physicians, should reduce the instances of payouts and exert
downward pressure on premiums. Hopefully this will keep the
instruments affordable and offer the right value of contingency
planning for patients. The policy’s underwriters at Lloyd’s86 are
surely capable of replicating a quality-driven regime in the United
States that will not price out patients and drive them to lower cost,
lower quality treatment locations.
Insurance coverage such as MTS protects the patient from
exorbitant out of pocket expenses for emergent or revision treatment
as a result of the original care.87 Since many of the outbound
international patients addressed by this Article are financially
vulnerable when it comes to healthcare expenses, the cost of follow81

See MTS Key Facts, supra note 77, at 5.
See PATIENTS BEYOND BORDERS, supra note 14 (estimating the range of cost
savings for American patients in popular treating nations).
83
How
Much
Does
it
Cost?,
MED.
TRAVEL
SHIELD,
http://medicaltravelshield.com/how-much-does-it-cost (last visited Feb. 8, 2015).
84
See PATIENTS BEYOND BORDERS, supra note 14 (estimating the range of cost
savings for American patients in popular treating nations).
85
See ISAPS INS., The Policy, supra note 72.
86
See MTS Key Facts, supra note 77, at 8.
87
See MTS Key Facts, supra note 77.
82
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up care is likely to fall on the public health system, specifically
Medicare, Medicaid, or the hospital whose emergency room admits
the patient.88 Therefore, procedure-specific insurance also protects the
patient’s home country from bearing the cost of malpractice and it
does so in a far more economical way than purchasing traditional
health coverage. Outbound American patients need such an option,
and since it would benefit the public healthcare system, institutions
like the Centers for Disease Control and Prevention and the
Department of State should produce public service content on the
subject.
Each American Embassy and Consulate typically has a United
States Citizen Service section that lists available services in the
diplomatic mission’s district, including healthcare.89 This site would
be the ideal place to educate patients about available healthcare
coverage as well as legal recourse options in the event of malpractice.
Combined with expanding the main State Department travel website
to include the same information on each country, such public outreach
would be extremely effective in channeling patient behavior.90 These
organizations are valuable conduits of information because so many
people reference their websites before travelling to identify needed
travel vaccines, visa requirements, and travel advisories. Integrating
information into these sites about healthcare quality, options for
malpractice claims, and available self-insurance products will provide
outbound patients with information about international healthcare that
is relevant to making an informed decision about their choice in care.
It would encourage patients to seek care in an environment that
provides coverage and recourse at a level that satisfies patient
expectations and with which they are comfortable. It will encourage
better care and remedy and effectively channel patients into a higher
quality care environment.

88

See COHEN, supra note 1, at 96–97.
See e.g., U.S. Citizen Services: Lawyers and Doctors, EMBASSY OF THE U.S.:
SAN JOSE, COSTA RICA, http://costarica.usembassy.gov/service/lawyers-anddoctors2.html (last visited Feb. 3, 2015) (listing typical information found on the
website or from the office of each American diplomatic mission).
90
See COHEN, supra note 1, at 108–15.
89
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B. Keeping Physicians Engaged
The obverse party in the international healthcare relationship
is the physician. For all of the reasons detailed above, physicians have
powerful incentives to both offer patients remedy and mitigate the
potential costs of those remedies to preserve the financial savings they
offer. If physicians continue to present no remedy in the face of high
profile adverse outcomes, they will forfeit their opportunity to attract
patients. However, if transaction costs associated with remedies erode
cost savings, physicians will once again forfeit their chances at
winning over American patients. Finally, if the only option is to pay
out-of-pocket for corrective care in the United States and be hauled
before an American court, many physicians will walk away from the
American market, focusing instead on patients from a less litigious
society where big damage awards are less common.91 The treating
countries share the same concerns as individual physicians; not
because of the prospect for personal financial ruin, but for the
possibility of massive losses to the national reputation affecting many
economic sectors.92 The country’s worries aggregate those of all the
individual physicians with added concern over harming the tourism,
hospitality, and travel sectors of their economy.93
The ISAPS Insurance regime protects these interests as well.
Once again, the insurance attempts to use quality indicators to keep
complication rates, and therefore premiums, low.94 The plan limits the
physician’s exposure by allowing them to choose their indemnity to
between 2,000 and 15,000 in either American Dollars, Euro, or
Pounds.95 The operating physician pays a premium of six percent of
the indemnity coverage.96 As a result, the patient receives coverage
91

Wiener, supra note 54.
See Jonathan Head, The Dark Side of Cosmetic Surgery in Thailand, BBC
NEWS (Feb. 12, 2015), http://www.bbc.com/news/business-31433890 (suggesting
specific cases implicate the overall quality of Thai healthcare).
93
See Kelley, supra note 9 (noting Singapore received 850,000 patients in 2012
generating $3.5 billion in revenue); See also Connell, supra note 36, at 132-33
(noting medical tourists spend two to three times more than standard tourists with a
significant amount of spending outside of healthcare and creating many nonhealthcare jobs).
94
See ISAPS, The Policy, supra note 72.
95
Surgeon’s Guide, ISAPS INS., http://isapsinsurance.com/documents (last
visited Feb. 25, 2015).
96
Id.
92
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for corrective procedures for up to two years following the original
treatment.97 Especially important in the context of international
healthcare, if the patient-physician relationship has broken down or it
is not possible for the patient to return to the original physician, the
insurance will cover the correction by a highly trained and qualified
surgeon in the patient’s home country.98
The resulting remedy helps bridge the gap between a
potentially crippling financial award and leaving the patient out in the
cold with no options. If a physician coverage regime were employed
reasonably and in conjunction with patient purchased coverage, the
adverse outcomes would be less acerbic except in the most extreme
cases. Just like cases in domestic healthcare, any adverse outcome is
sensitive but when patients have options, the situation is less likely to
balloon into a damaging media firestorm that harms the physician’s
and nation’s reputation.
The premiums involved are modest but do consume some of
the cost savings foreign providers tend to present, which can
challenge the allure of international healthcare.99 As costs increase,
patients may be more likely to bypass protections and go to another
provider. Perhaps patients will be won over by more impressive
marketing and patient testimonials, thinking the additional insurance
unnecessary in a location that looks, but might not actually be, higher
quality. Alternatively, some patients may simply opt to stay home.100
It is difficult to strike a balance in the international healthcare
market. Physicians must attract patients by demonstrating comparable
quality to that available in the patient’s home country. They must also
be careful not to over trivialize healthcare into a purely consumer
endeavor so that patients believe they can go anywhere and be treated
safely. And they must do so while offering sizeable cost savings. The
phrase “but it was just a minor procedure” abounds. Patient and
physician insurance policies offer a significant development capable
97

Id.
Id.
99
See Deloitte, Consumers in Search of Value, supra note 9, at 6 (identifying
cost savings as a key driver in international healthcare).
100
See Deloitte Center for Health Solutions, Medical Tourism: Update and
Implications
1,
11
(2009)
http://www.deloitte.com/assets/DcomUnitedStates/Local%20assets/documents/us_chs_medicaltourism_111209_web.pdf
(indicating a fifty percent cost saving is a critical threshold to get patients to travel
outside their community for care).
98
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of protecting those who seek care abroad before costs are incurred and
in a way that limits the exposure of both parties to financial distress.
VII. CONCLUSION
The people who seek foreign care are not merely passengers,
travelers, consumers, or customers. They are patients, and it is the
responsibility of the legal profession to keep that distinction in focus,
while helping foster the appropriate protective institutions. The large
number of patients traveling for care, whom have not been
incentivized to do so by employers or insurers, are utterly exposed at
present. They have no opportunity to recover for malpractice. As a
result, the patients and the American healthcare system risk absorbing
the cost of complications on a personal and national level. In the
absence of a universally recognized international court system to
enforce malpractice judgments, which seems unlikely, a network of
bi-lateral institutions is needed.
The Romulus and Remus of international medical malpractice
have been born in the form of Costa Rica’s bi-lateral alternative
dispute resolution forum and ISAPS’ procedure-specific insurance
regime. These are not mature and finished solutions. They are the
infant versions of what will eventually emerge to offer patients
malpractice protection. These schemes must be studied, emulated, and
improved upon to create an international healthcare system that
approximates the protections American patients enjoy at home
without driving costs beyond reach.
The solutions discussed in this Article pose the greatest
benefit to the independent patient seeking outpatient care in an
unaffiliated clinic. Such patients act without the prodding of an
employer or insurer, and without the help of a facilitator. Therefore,
no established theories of liability exist to give these patients recourse
against tortfeasors in American courts. However, even if American
case law develops to hold domestic agents liable for foreign
malpractice against insured patients or those who have been referred
to international care by their employer, the regimes discussed herein
would still add an additional layer of patient consumer protection that
is currently unavailable.

